BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/4/2016 10:08:00 AM | Browse: 1340 | Download: 3254
Publication Name World Journal of Gastroenterology
Manuscript ID 23607
Country China
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ Peer-review started: February 25, 2016
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Surgery
Manuscript Type Basic Study
Article Title Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis
Manuscript Source Unsolicited Manuscript
All Author List Cheng-Gang Zhang, Bin Zhang, Wen-Sheng Deng, Ming Duan, Wei Chen and Zhi-Yong Wu
Funding Agency and Grant Number
Funding Agency Grant Number
National Natural Science Foundation for the Youth of China 81400630
Corresponding Author Zhi-Yong Wu, MD, PhD, Department of Gastrointestinal Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, No. 1630 Dongfang Road, Shanghai 200127, China. zhiyongwu1949@sina.com
Key Words Portal hypertension; Estrogen receptor; Rho-kinase signaling; Nitric oxide; Hepatic stellate cells
Core Tip Liver cirrhosis and portal hypertension (PHT) are subject to gender and estrogen levels. The aim of the present study was to investigate whether estrogen receptor β selective agonists could ameliorate intrahepatic resistance and mitigate PHT in rats with CCl4-induced cirrhosis, and uncover the underlying mechanism by investigating RhoA/ROCK and NO/PKG signaling. The authors propose that treatment with an estrogen receptor β selective agonist could improve cirrhotic PHT via regulating RhoA/ROCK and NO/PKG signaling.
Publish Date 2016-05-04 10:08
Citation Zhang CG, Zhang B, Deng WS, Duan M, Chen W, Wu ZY. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis. World J Gastroenterol 2016; 22(18): 4484-4500
URL http://www.wjgnet.com/1007-9327/full/v22/i18/4484.htm
DOI http://dx.doi.org/10.3748/wjg.v22.i18.4484
Full Article (PDF) WJG-22-4484.pdf
Full Article (Word) WJG-22-4484.doc